AL
LKFT

Airain Ltd’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Airain Ltd’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$934K Buy
12,204
+9,455
+344% +$795K 0.04% 424
2017
Q1 		$237K Buy
+2,749
New +$198K 0.01% 689
2016
Q1 		– Sell
-7,541
Closed -$474K – 892
2015
Q4 		$474K Buy
+7,541
New +$385K 0.03% 473

Other funds holding LKFT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Airain Ltd's LKFT Position: Q2 2017 in Review

Airain Ltd increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 344% in Q2 2017, buying an estimated $795K and bringing the position to 12,204 shares worth $934K. The position accounts for 0.04% of the portfolio, ranked #424.

Airain Ltd first reported a position in LKFT in Q4 2015 and has held it in 3 quarters since. 78 funds tracked by Wall St. Rank hold LKFT as of Q2 2017.

  • Airain Ltd held 12,204 shares of Lakefront Biotherapeutics American Depositary Shares worth $934K as of Q2 2017.
  • Airain Ltd bought 9,455 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2017, an estimated $795K.
  • Lakefront Biotherapeutics American Depositary Shares made up 0.04% of Airain Ltd's portfolio in Q2 2017, its #424 holding.
  • Airain Ltd first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2015 and has held it in 3 quarters since.
  • 78 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.